ChemoCentryx
ChemoCentryx is a California-based biopharmaceutical company that develops orally-administered therapeutics for the treatment of cancer, inflammatory and autoimmune diseases.
Business Model:
Revenue: $37.3M
Employees: 51-200
Rankings
Industries / Tags:
Detailed ChemoCentryx Information
ChemoCentryx was acquired by
Amgen.
The acquisition happend on 2022-08-04.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 835 Industrial Road
City: San Carlos
State: CA
Zip: 94070
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$325M
Raised Total:$634M
Social
Metrics
1,613,610Website Global Rank
15,085Website Monthly Traffic
Twitter Followers
Description
ChemoCentryx is a California-based biopharmaceutical company that develops orally-administered therapeutics for the treatment of cancer, inflammatory and autoimmune diseases.
Contact Phone:
+16502102900
Contact Email:
ChemoCentryx went public on 2/8/2012 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/8/2012
Ticker Symbol:
CCXI
IPO Price:
$10/share
Amount Raised:
$45M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
